Exhibit 99.3

CONSOLIDATED BALANCE SHEETS

(U.S. dollars in thousands)

	March 31, 2022			December 31, 2021
*Current Assets:*	(Unaudited)			(Audited)
Cash and cash equivalents		87,255			100,811
Restricted cash		132			125
Short term bank deposits		400			-
Trade Receivable		653			187
Prepaid expenses and other receivables		3,397			3,058
Total current assets		91,837			104,181

*Non-Current Assets*
Operating lease right-of-use assets		738			-
Property and equipment, net		1,375			1,165
Total non-current assets		2,113			1,165

Total assets		93,950			105,346

*Current liabilities:*
Short term loan		5,063			4,916
Trade payables		1,412			2,005
Operating lease liabilities		396			-
Employees and payroll accruals		3,467			3,095
Deferred revenues		731			726
Accrued expenses and other payables		1,860			4,725
Total current liabilities		12,929			15,467

*Long term liabilities*
Operating lease liabilities		326
Warrant Liability		6,774			10,056
Total long-term liabilities		7,100			10,056

SHAREHOLDERS’ EQUITY:
Ordinary Shares		*	)		*	)
Additional paid-in capital		201,423			199,469
Accumulated Deficit		(127,502	)		(119,646	)
Total shareholders’ equity		73,921			79,823

Total liabilities and shareholders’ equity		93,950			105,346

Represents less than $1.

CONSOLIDATED STATEMENTS OF OPERATIONS

(U.S. dollars in thousands, except share and per share data)

	3 Months Ended			3 Months Ended
	March 31, 2022			March 31, 2021
	(Unaudited)			(Unaudited)
Revenues		876			580
Cost of revenues		384			323
Gross Profit		492			257

Operating Expenses:
Research and development, net		7,803			3,711
Sales and marketing		1,182			295
General and administrative		2,145			521
Total operating expenses		11,130			4,527

Operating loss		(10,638	)		(4,270	)

Financial expenses (Income), net		(2,782	)		14,106

Net loss		(7,856	)		(18,376	)

Basic and diluted net loss per share attributable to Ordinary Shareholders		(0.12	)		(1.98	)

Weighted-average number of shares used in computing basic and diluted net loss per share attributable to Ordinary Shareholders*		63,034,545			9,300,548

The number of ordinary shares retroactively reflects the 46.25783-for-one stock split of the ordinary shares which was effective on October 7, 2021.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(U.S. dollars in thousands)

	3 Months Ended			3 Months Ended
	March 31, 2022			March 31, 2021
Cash flows from operating activities:	(Unaudited)			(Unaudited)
Net Loss		(7,856	)		(18,376	)

Adjustments to reconcile loss to net cash used in operating activities:
Depreciation		105			53
Stock-based compensation		1,790			146
Warrants to service providers		69			19
Revaluation of warrants and accretion		(3,135	)		3,275
Revaluation of convertible loan		-			10,762

Change in operating assets and liabilities:
Increase in trade receivable		(465	)		(271	)
Increase in prepaid expenses and other receivables		(339	)		(219	)
Operating lease ROU assets and liabilities, net		(16	)		-
Increase (decrease) in trade payables		(668	)		66
Increase in employees and payroll accruals		372			105
Increase in deferred revenue		5			34
Increase (decrease) in accrued expenses and other payables		(2,865	)		364

Net cash used in operating activities		(13,003	)		(4,042	)

Cash flows from investing activities:
Change in bank deposits		(400	)		-
Purchase of property and equipment		(242	)		(340	)

Net cash used in investing activities		(642	)		(340	)

Cash flows from financing activities:
Repayment of long-term loan		-			(451	)
Proceeds from exercise of warrants		-			2,440
Proceeds from exercise of options		96			34
Proceeds from convertible loan		-			11,337

Net cash provided by financing activities		96			13,360

Increase (decrease) in cash, cash equivalents and restricted cash		(13,549	)		8,978
Cash, cash equivalents and restricted cash at the beginning of the year		100,936			2,954

Cash, cash equivalents and restricted cash at the end of the period		87,387			11,932

RECONCILIATION OF GAAP NET LOSS TO NON-GAAP NET LOSS

(U.S. dollars in thousands, except share and per share data)

	3 Months Ended			3 Months Ended
	March 31, 2022			March 31, 2021
	(Unaudited)			(Unaudited)
GAAP net loss attributable to ordinary shareholders		(7,856	)		(18,376	)

Add:
Stock-based compensation		1,790			146
Warrants to service providers		69			19
Revaluation of warrants and accretion		(3,135	)		3,275
Revaluation of convertible loan		-			10,762
Non-recurring initial public offering expenses		130			-

Non-GAAP net loss		(9,002	)		(4,174	)

Basic and diluted Non-GAAP net loss per share attributable to Ordinary Shareholders		(0.14	)		(0.45	)

Weighted-average number of shares used in computing basic and diluted Non-GAAP net loss per share attributable to Ordinary Shareholders*		63,034,545			9,300,548

The number of ordinary shares retroactively reflects the 46.25783-for-one stock split of the ordinary shares which was effective on October 7, 2021.

RECONCILIATION OF GAAP NET LOSS TO AJUSTED EBITDA

(U.S. dollars in thousands)

	3 Months Ended			3 Months Ended
	March 31, 2022			March 31, 2021
	(Unaudited)			(Unaudited)
GAAP net loss attributable to ordinary shareholders		(7,856	)		(18,376	)

Add:
Financial expenses, net		(2,782	)		14,106
Depreciation		105			53
Stock-based compensation		1,790			146
Warrants to service providers		69			19
Non-recurring initial public offering expenses		130			-

Adjusted EBITDA		(8,544	)		(4,052	)